Barclays’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-2,493
Closed -$271K – 5486
2020
Q1
$271K Sell
2,493
-3,588
-59% -$641K ﹤0.01% 4068
2019
Q4
$1.58M Sell
6,081
-2,962
-33% -$1.1M ﹤0.01% 3236
2019
Q3
$4.76M Buy
9,043
+5,276
+140% +$3.91M ﹤0.01% 1893
2019
Q2
$3.54M Buy
+3,767
New +$3.79M ﹤0.01% 2231

Other funds holding ACB

Barclays's ACB Position: Q3 2026 in Review

Barclays increased its Aurora Cannabis (ACB) stake by 3.6% in Q3 2026, buying an estimated $2.72K and bringing the position to 22,801 shares worth $88.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4358.

Barclays first reported a position in ACB in Q4 2018 and has held it in 25 quarters since. The position peaked at $3.12M in Q2 2019. 157 funds tracked by Wall St. Rank hold ACB as of Q3 2026.

  • Barclays held 22,801 shares of Aurora Cannabis worth $88.9K as of Q3 2026.
  • Barclays bought 800 Aurora Cannabis shares in Q3 2026, an estimated $2.72K.
  • Aurora Cannabis made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4358 holding.
  • Barclays first reported a position in Aurora Cannabis in Q4 2018 and has held it in 25 quarters since.
  • Barclays's Aurora Cannabis position peaked at $3.12M in Q2 2019.
  • 157 funds tracked by Wall St. Rank held Aurora Cannabis as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.